Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Ray Kim

Showing results (141-150 of 248) with videos related to

Pageof 25
Sort By:
Journal of Hepatology|April 10, 2014
Chronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rateAlina M Allen, W Ray Kim, Terry M Therneau, et al.
The American Journal of Gastroenterology|August 17, 2016
Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C CirrhosisJu Dong Yang, Hager Amed Mohamed, Jessica L Cvinar, et al.
Hepatology (Baltimore, Md.)|October 18, 2024
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice GuidanceVincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Hepatology Communications|October 4, 2024
Infections in decompensated cirrhosis: Pathophysiology, management, and research agendaJessica Ferguson Toll, Elsa Solà, Maria Alejandra Perez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 17, 2024
Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood typeMiho Akabane, Yuki Bekki, Yosuke Inaba, et al.
Biomed Research International|June 20, 2024
Timely Albumin Infusion May Improve Resource Utilization in Patients with Cirrhosis and Spontaneous Bacterial PeritonitisW Ray Kim, Karthik Raghunathan, Greg S Martin, et al.
Gastroenterology|February 22, 2011
A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantationMichael D Leise, W Ray Kim, Walter K Kremers, et al.
Hepatology (Baltimore, Md.)|February 14, 2025
Reply: AASLD Resmetirom GuidanceVincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiationSarwa Darwish Murad, Julie K Heimbach, Gregory J Gores, et al.
Journal of Hepatology|October 4, 2014
Reply to: "Chronic kidney disease after liver transplantation"Alina M Allen, W Ray Kim, Terry M Therneau, et al.
Pageof 25

Showing results (141-150 of 248) with videos related to

Sort By:
Pageof 25
Journal of Hepatology|April 10, 2014
Chronic kidney disease and associated mortality after liver transplantation--a time-dependent analysis using measured glomerular filtration rateAlina M Allen, W Ray Kim, Terry M Therneau, et al.
The American Journal of Gastroenterology|August 17, 2016
Diabetes Mellitus Heightens the Risk of Hepatocellular Carcinoma Except in Patients With Hepatitis C CirrhosisJu Dong Yang, Hager Amed Mohamed, Jessica L Cvinar, et al.
Hepatology (Baltimore, Md.)|October 18, 2024
Resmetirom therapy for metabolic dysfunction-associated steatotic liver disease: October 2024 updates to AASLD Practice GuidanceVincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Hepatology Communications|October 4, 2024
Infections in decompensated cirrhosis: Pathophysiology, management, and research agendaJessica Ferguson Toll, Elsa Solà, Maria Alejandra Perez, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 17, 2024
Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood typeMiho Akabane, Yuki Bekki, Yosuke Inaba, et al.
Biomed Research International|June 20, 2024
Timely Albumin Infusion May Improve Resource Utilization in Patients with Cirrhosis and Spontaneous Bacterial PeritonitisW Ray Kim, Karthik Raghunathan, Greg S Martin, et al.
Gastroenterology|February 22, 2011
A revised model for end-stage liver disease optimizes prediction of mortality among patients awaiting liver transplantationMichael D Leise, W Ray Kim, Walter K Kremers, et al.
Hepatology (Baltimore, Md.)|February 14, 2025
Reply: AASLD Resmetirom GuidanceVincent L Chen, Timothy R Morgan, Yaron Rotman, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|March 1, 2013
Excellent quality of life after liver transplantation for patients with perihilar cholangiocarcinoma who have undergone neoadjuvant chemoradiationSarwa Darwish Murad, Julie K Heimbach, Gregory J Gores, et al.
Journal of Hepatology|October 4, 2014
Reply to: "Chronic kidney disease after liver transplantation"Alina M Allen, W Ray Kim, Terry M Therneau, et al.
Pageof 25